A randomized controlled pilot study assessing the effect of sitagliptin on the preservation of beta-cell function in patients with type 2 diabetes.

Trial Profile

A randomized controlled pilot study assessing the effect of sitagliptin on the preservation of beta-cell function in patients with type 2 diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Dec 2011

At a glance

  • Drugs Metformin; Sitagliptin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms BEST
  • Most Recent Events

    • 30 Jun 2010 Status changed from active, no longer recruiting to completed, based on the results being presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
    • 30 Jun 2010 Presented at the 70th Annual Scientific Sessions of the Amercian Diabetes Association
    • 14 Dec 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top